The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay
Open Access
- 13 January 2006
- journal article
- research article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 4 (2), 377-384
- https://doi.org/10.1111/j.1538-7836.2006.01730.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Effectiveness of factor VIII infusions in haemophilia A patients with high responding inhibitorsHaemophilia, 2004
- Usefulness of synthetic phospholipid in measurement of activated partial thromboplastin time: a new preparation procedure to reduce batch differenceInternational Journal of Laboratory Hematology, 2004
- Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitorsJournal of Thrombosis and Haemostasis, 2004
- Standardization of the endogenous thrombin potential measurement: how to minimize the effect of residual platelets in stored plasmaBritish Journal of Haematology, 2004
- Understanding the hemostatic effects of recombinant factor VIIa by clot wave form analysisSeminars in Hematology, 2004
- Monitoring the bioavailability of FEIBA with a thrombin generation assayJournal of Thrombosis and Haemostasis, 2003
- Mechanism of factor VIIa–dependent coagulation in hemophilia bloodBlood, 2002
- The Utility of activated Partial Thromboplastin Time (aPTT) Clot Waveform Analysis in the Investigation of Hemophilia A Patients with very Low Levels of Factor VIII Activity (FVIII:C)Thrombosis and Haemostasis, 2002
- Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vectorNature Genetics, 2000
- Biochemistry and Physiology of Blood CoagulationThrombosis and Haemostasis, 1999